- Home
- PHK vs CRMD Comparison
PHK vs CRMD Comparison
Compare PHK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHK
- CRMD
- Stock Information
- Founded
- PHK 2003
- CRMD 2006
- Country
- PHK United States
- CRMD United States
- Employees
- PHK N/A
- CRMD N/A
- Industry
- PHK Finance/Investors Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PHK Finance
- CRMD Health Care
- Exchange
- PHK Nasdaq
- CRMD Nasdaq
- Market Cap
- PHK 842.0M
- CRMD 865.2M
- IPO Year
- PHK N/A
- CRMD 2010
- Fundamental
- Price
- PHK $4.86
- CRMD $10.18
- Analyst Decision
- PHK
- CRMD Strong Buy
- Analyst Count
- PHK 0
- CRMD 8
- Target Price
- PHK N/A
- CRMD $17.57
- AVG Volume (30 Days)
- PHK 491.5K
- CRMD 2.2M
- Earning Date
- PHK 01-01-0001
- CRMD 11-10-2025
- Dividend Yield
- PHK 12.61%
- CRMD N/A
- EPS Growth
- PHK N/A
- CRMD N/A
- EPS
- PHK N/A
- CRMD 0.79
- Revenue
- PHK N/A
- CRMD $121,484,498.00
- Revenue This Year
- PHK N/A
- CRMD $480.51
- Revenue Next Year
- PHK N/A
- CRMD $59.81
- P/E Ratio
- PHK N/A
- CRMD $12.86
- Revenue Growth
- PHK N/A
- CRMD 14970.29
- 52 Week Low
- PHK $4.13
- CRMD $5.60
- 52 Week High
- PHK $5.15
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- PHK 34.04
- CRMD 33.70
- Support Level
- PHK $4.86
- CRMD $10.39
- Resistance Level
- PHK $4.99
- CRMD $10.94
- Average True Range (ATR)
- PHK 0.04
- CRMD 0.45
- MACD
- PHK -0.02
- CRMD -0.07
- Stochastic Oscillator
- PHK 38.35
- CRMD 9.71
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.